MétaCan
Menu
← Back to cohort

Bilateral mastectomy and breast cancer mortality for invasive lobular carcinoma: A SEER-based study.

2025· article· en· W4410809220 on OpenAlexaff
Richa Jaiswal, David W. Lim, Vasily Giannakeas

Bibliographic record

VenueJournal of Clinical Oncology · 2025
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicBRCA gene mutations in cancer
Canadian institutionsWomen's College HospitalUniversity of Toronto
Fundersnot available
KeywordsMedicineBreast cancerCancerMastectomyOncologyInvasive lobular carcinomaGeneral surgeryInternal medicineGynecologyInvasive ductal carcinoma

Abstract

fetched live from OpenAlex

585 Background: Many women with unilateral breast cancer opt for bilateral mastectomy. While removing the unaffected contralateral breast lowers the risk of second primary cancers, there is no benefit on breast cancer mortality. Studies have not investigated whether this holds true for invasive lobular carcinoma (ILC). To estimate the 20-year risk of breast cancer mortality in women with stage I-III unilateral ILC and compare survival outcomes between unilateral lumpectomy, unilateral mastectomy and bilateral mastectomy. Methods: This retrospective cohort study used the Surveillance, Epidemiology, and End Results (SEER) database to identify women diagnosed with unilateral invasive lobular carcinoma (ILC) between 2000 and 2020. The cohort was followed for up to 20 years to assess contralateral breast cancer and breast cancer-specific survival. We estimated crude mortality rates, 20-year cumulative breast cancer mortality, and hazard ratios by surgical treatment group. Kaplan-Meier was used for cumulative risk, and Cox proportional hazards models for unadjusted and adjusted hazard ratios with 95% confidence intervals. P-values < 0.05 were considered significant. Results: We identified 58,861 women with unilateral ILC. Of which, 34,561 (59%) had lumpectomy, 18,894 (32%) had unilateral mastectomy, and 5406 (9.1%) had bilateral mastectomy. The mean age (in years) was 64 ±11 for unilateral lumpectomy, 62 ±13 for unilateral mastectomy, and 57±11 for bilateral mastectomy (p < 0.0001). The mean tumour size was smallest in the lumpectomy group (1.9±1.5 cm) compared with 3.6± 3 cm in both unilateral and bilateral mastectomy groups (p < 0.0001). The 20-year cumulative invasive contralateral breast cancer risk was 7.3% for lumpectomy, 7.5% for unilateral mastectomy, and 0.3% for bilateral mastectomy. The 20-year cumulative breast cancer mortality was 13.4% in the lumpectomy group, 30.2% in unilateral mastectomy group and 24.3% in bilateral mastectomy group. However, after adjusting for demographic, clinical, and treatment variables, we observed no difference in breast cancer mortality rates among unilateral mastectomy patients versus lumpectomy patients (adjusted hazard ratio [aHR], 1.01; 95% CI, 0.94–1.08), and a statistically significant reduction in breast cancer mortality rates among bilateral mastectomy patients compared to lumpectomy patients (aHR, 0.90; 95% CI, 0.82–1.00; p value 0.04). Conclusions: In this cohort of invasive lobular breast cancer, bilateral mastectomy patients had a significantly lower risk of contralateral breast cancer and, after adjusting for differences in the surgical treatment groups, had a 10% lower rate of breast cancer mortality as compared to lumpectomy patients.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.012
Threshold uncertainty score0.024

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.002
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.001
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.001
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.074
GPT teacher head0.452
Teacher spread0.377 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Clinical Oncology→Same topicBRCA gene mutations in cancer→French-language works237,207→